Prostate Screening Tests Used Even if They Don’t Provide Value
Shifting guidelines for prostate cancer screening lead to uncertainty on when and if prostate screening tests should be ordered.
Category: Prostate
Prostate
Latest
Prostate
Latest
Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk Disease
A new study investigated genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
Prostate
Latest
Metastatic Prostate Cancer on the Rise as Screenings Decreased
The incidence rate of metastatic prostate cancer increased for men 45 and older and coincides with recommendations against screenings.
PSA Testing Rates Increased After National Guidelines Revised
In a large study, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions by the USPSTF on screening.
Read More
Study Reveals Racial, Ethnic Disparities in Use of Prostate Cancer Test
Black, Hispanic, and Asian men were less likely to receive a popular prostate cancer test that can eliminate the need for an invasive biopsy.
Read More
Prostate Cancer Urine Test Identifies Good Prognosis Patients
A prostate cancer urine test can identify men at intermediate risk who can safely avoid immediate treatment and benefit from active surveillance instead.
Read More
Targeted PSA Testing Could Benefit Men with Lynch Syndrome
Researchers believe that men with Lynch syndrome could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer.
Read More
Roche and Ibex to Collaborate on AI-Based Digital Pathology Applications
Roche has entered an agreement with Ibex Medical Analytics, a provider of artificial intelligence (AI)-based cancer diagnostics.
Read More
Canines Are Top Dogs vs. Technology in Detecting Prostate Cancer
New research from a team of scientists — and two specially trained dogs — have scientifically validated man’s best friend can “sniff out” prostate cancer.
Read More
Noninvasive Tests for Colon, Prostate Cancer May Improve Screening Compliance
Researchers have developed noninvasive tests that use either blood or saliva samples to diagnose colorectal cancer or prostate cancer, respectively.
Read More
FDA Has Authorized Software That Can Assist Prostate Cancer Diagnosis
The U.S. Food and Drug Administration (FDA) has authorized marketing of software to assist medical pathologists in detecting areas suspicious for cancer.
Read More
Spotlight Is on Prostate Cancer Testing in September
During the pandemic, studies have shown many men are missing or delaying routine health screenings, including prostate cancer screenings.
Read More
Novel Blood Test Can Cut Prostate Cancer Biopsies by a Third
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging...
Read More
JAMA Study: Covid-19 Had Significant Consequences for Cancer Screening
Because of the covid-19 pandemic, nearly 10 million patients weren’t screened for cancer, including breast, colorectal, and prostate.
Read More
New Line of Urology Testing to Screen for Prostate Cancer and Renal Cancer Hereditary Genetics
Medical Diagnostic Laboratories’ approach blends DNA-based molecular testing with traditional pathology and cytology tests to aid in diagnosing or screening for urologic conditions.
Read More
Improved Prostate Cancer Diagnosis with AI-powered Workflows
Proscia and Ibex Medical Analytics are collaborating to deliver a unified software solution that powers AI-enabled workflows for prostate cancer diagnosis.
Read More
Learning from Prostate Cancer-Detecting Dogs to Improve Diagnostics
New research demonstrates the ability of dogs to detect aggressive prostate cancer from urine samples and suggests that an artificial neural network could learn from this olfactory ability, with an eye toward replicating it in novel detection tools.
Read More
Propella Therapeutics, National Cancer Institute to Develop Treatment for Metastatic Prostate Cancer
Under this new partnership, Propella and NCI will conduct a multi-center clinical trial to evaluate abiraterone decanoate as a new therapy for metastatic prostate cancer.
Read More